Investment accounts
Adult accounts
Child accounts
Choosing Fidelity
Choosing Fidelity
Why invest with us Current offers Fees and charges Open an account Transfer investments
Financial advice & support
Fidelity’s Services
Fidelity’s Services
Financial advice Retirement Wealth Management Investor Centre (London) Bereavement
Guidance and tools
Guidance and tools
Choosing investments Choosing accounts ISA calculator Retirement calculators
Share dealing
Choose your shares
Tools and information
Tools and information
Share prices and markets Chart and compare shares Stock market news Shareholder perks IPOs and placings
Pensions & retirement
Pensions, tax & tools
Saving for retirement
Approaching / In retirement
Approaching / In retirement
Speak to a specialist Creating a retirement plan Taking tax-free cash Pension drawdown Annuities Investing in retirement Investment Pathways
London pre-open: Stocks seen higher; retail sales disappoint
(Sharecast News) - London stocks were set to rise at the open on Friday following heavy losses a day earlier, as investors mulled disappointing retail sales data. The FTSE 100 was called to open up around 15 points.
Figures released earlier by the Office for National Statistics showed that retail sales unexpectedly fell in October as wet weather and the cost-of-living crisis took their toll.
Retail sales fell 0.3% on the month following a revised 1.1% decline in September, missing expectations for a 0.3% increase.
Heather Bovill, deputy director for surveys and economic indicators at the ONS, said: "Retail sales fell again in October to their lowest level since February 2021 when widespread lockdown restrictions were in place.
"After rebounding in September, fuel sales dipped with increasing prices discouraging customers, while food sales also dropped as consumers prioritised essential goods.
"It was another poor month for household goods and clothes stores with these retailers reporting that cost-of-living pressures, reduced footfall and poor weather hit them hard.
"However, it was a better month for online retailers, the only main sector to report growth in October."
In corporate news, AstraZeneca's Truqap, in combination with Faslodex, has received US FDA approval for treating adults with hormone receptor-positive, HER2-negative locally advanced or metastatic breast cancer with specific biomarker alterations and who previously progressed on endocrine-based therapy.
The approval is based on positive results from a phase three trial, showing a 50% reduction in the risk of disease progression or death when compared to Faslodex alone in patients with relevant biomarker alterations.
AstraZeneca said the approval addressed a significant need in breast cancer treatment, as the biomarker alterations affected up to 50% of advanced HR-positive breast cancer patients who develop resistance to first-line therapies.
Aberdeen-based transport company FirstGroup signed a deal with Hitachi that will see it buy up to 1,000 electric bus batteries as it works towards is decarbonisation targets.
The partnership will see the creation of a new 50:50 joint venture, NextGen Asset Co, to buy the batteries valued at £100m, leased over an eight-year period. In exchange, Hitachi will provide battery and charging management services for 1,000 buses powered by the new batteries.
Share this article
Related Sharecast Articles
Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.
Award-winning online share dealing
Search, compare and select from thousands of shares.
Expert insights into investing your money
Our team of experts explore the world of share dealing.
Policies and important information
Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity and Inclusion | Doing Business with Fidelity | Fidelity gender pay report | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Security | Statutory and Regulatory disclosures | Whistleblowing policy
Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document which contains important information about the fund.
This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.